Taylor, Joby <br/><br/>
Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.  [electronic resource] 

 -  BJU international  May 2009 
 - 1392-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-410X 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-410X.2008.08328.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carbolines--adverse effects<br/>Erectile Dysfunction--drug therapy<br/>Humans<br/>Imidazoles--adverse effects<br/>Male<br/>Middle Aged<br/>Patient Satisfaction<br/>Phosphodiesterase Inhibitors--adverse effects<br/>Piperazines--adverse effects<br/>Prospective Studies<br/>Purines--adverse effects<br/>Sildenafil Citrate<br/>Sulfones--adverse effects<br/>Surveys and Questionnaires<br/>Tadalafil<br/>Time Factors<br/>Triazines--adverse effects<br/>Vardenafil Dihydrochloride